The ones who attended the recent CannX-2022 conference heard a lot about the overwhelming medical benefits of cannabis.
The need for evidence-based clinical trials was voiced loudly. In general, Israel is a well known for conducting high quality clinical trials. Although the approval process for cannabis clinical trials is challenging, we believe that prior knowledge and proper planning could be of benefit when Israel is chosen to participate is such clinical trials.

For initial guidance and recommendations:
https://gcp.co.il/publication/clinical-trials-with-cannabis-guidance-for-approval-process-in-israel/

The professional team at GCP Clinical Studies will be happy to guide you through the local regulatory requirements and help you plan and manage your clinical trial.

XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System

IdentifAI Genetics is proud to announce the launching of strategic cooperation with Mor Research Applications, a Division of Clalit Health Services, the largest HMO in Israel and one of the most prominent health organizations globally.
 

Clalit’s top clinicians and researchers are ideal partners in our journey. Mor and Clalit’s endorsement and involvement constitute a first-rate seal of approval for IdentifAI’s mission to present a new generation of prenatal genetic testing platform.